Comparison of Long-Term Efficacy of the Paclitaxel-Eluting Stent Versus the Bare-Metal Stent for Treatment of Unprotected Left Main Coronary Artery Disease

American Journal of Cardiology

Volumn 103, Issue 2, 2009, Pages 194-198

  Han, Yaling ^a   Wang, Shouli ^a   Jing, Quanmin ^a   Li, Yi ^a   Liu, Haiwei ^a   Ma, Yingyan ^a   Wang, Zulu ^a   Wang, Dongmei ^a   Luan, Bo ^a   Wang, Geng ^a   Chen, Tao ^b  

^a SHENYANG NORTHERN HOSPITAL   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

ADULT; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION;

CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; REGISTRIES; RISK FACTORS; STENTS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 58149461681     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.058     Document Type: Article

References (27)

1. Park S.J., Hong M.K., Lee C.W., Kim J.J., Song J.K., Kang D.H., Park S.W., and Mintz G.S. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol 38 (2001) 1054-1060
2. Park S.J., Park S.W., Hong M.K., Lee C.W., Lee J.H., Kim J.J., Jang Y.S., Shin E.K., Yoshida Y., Tamura T., Kimura T., and Nobuyoshi M. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol 91 (2003) 12-16
3. Tan W.A., Tamai H., Park S.J., Plokker H.W., Nobuyoshi M., Suzuki T., Colombo A., Macaya C., Holmes Jr. D.R., Cohen D.J., Whitlow P.L., Ellis S.G., and ULTIMA Investigators. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 104 (2001) 1609-1614
4. Valgimigli M., van Mieghem C.A., Ong A.T., Aoki J., Granillo G.A., McFadden E.P., Kappetein A.P., de Feyter P.J., Smits P.C., Regar E., et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH and T-SEARCH) registries. Circulation 111 (2005) 1383-1389
5. Park S.J., Kim Y.H., Lee B.K., Lee S.W., Lee C.W., Hong M.K., Kim J.J., Mintz G.S., and Park S.W. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
6. Chieffo A., Stankovic G., Bonizzoni E., Tsagalou E., Iakovou I., Montorfano M., Airoldi F., Michev I., Sangiorgi M.G., Carlino M., Vitrella G., and Colombo A. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
7. Lee S.H., Ko Y.G., Jang Y., Kwon H.M., Lee S.H., Yoon J.H., Park S.H., Kim B.O., Jeon D.W., Yang J.Y., Ryu S.K., and Korean Multicenter Angioplasty Team (KOMATE) Investigators. Sirolimus- versus paclitaxel eluting stent implantation for unprotected left main coronary artery stenosis. Cardiology 104 (2005) 181-185
8. Valgimigli M., Malagutti P., Aoki J., Garcia-Garcia H.M., Rodriguez Granillo G.A., van Mieghem C.A., Ligthart J.M., Ong A.T., Sianos G., Regar E., et al. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEACH long-term analysis. J Am Coll Cardiol 47 (2006) 507-514
9. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
10. Roques F., Michel P., Goldstone A.R., and Nashef S.A. The logistic EuroSCORE. Eur Heart J 24 (2003) 882-883
11. Iakovou I., Ge L., and Colombo A. Contemporary stent treatment of coronary bifurcations. J Am Coll Cardiol 46 (2005) 1446-1455
12. Colombo A., Stankovic G., Orlic D., Corvaja N., Liistro F., Airoldi F., Chieffo A., Spanos V., Montorfano M., and Di Mario C. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter Cardiovasc Interv 60 (2003) 145-151
13. Chieffo A., Park S.J., Valgimigli M., Kim Y.H., Daemen J., Sheiban I., Truffa A., Montorfano M., Airoldi F., Sangiorgi G., et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation 116 (2007) 158-162
14. Biondi-Zoccai G.G., Lotrionte M., Moretti C., Meliga E., Agostoni P., Valgimigli M., Migliorini A., Antoniucci D., Carrié D., Sangiorgi G., et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J 155 (2008) 274-283
15. Kim Y.H., Dangas G.D., Solinas E., Aoki J., Parise H., Kimura M., Franklin-Bond T., Dasgupta N.K., Kirtane A.J., Moussa I., et al. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Am J Cardiol 101 (2008) 801-806
16. Khattab A.A., Hamm C.W., Senges J., Toelg R., Geist V., Bonzel T., Kelm M., Levenson B., Neumann F.J., Nienaber C.A., et al., German Cypher Registry. Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry. Heart 93 (2007) 1251-1255
17. Meliga E., Garcia-Garcia H.M., Valgimigli M., Chieffo A., Biondi-Zoccai G., Maree A.O., Cook S., Reardon L., Moretti C., De Servi S., et al. DELFT (Drug Eluting stent for LeFT main) Registry. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 51 (2008) 2212-2219
18. Sheiban I., Meliga E., Moretti C., Biondi-Zoccai G.G., Rosano G., Sciuto F., Marra W.G., Omedè P., Gerasimou A., and Trevi G.P. Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents. Am J Cardiol 100 (2007) 431-435
19. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., Colombo A., Schampaert E., Grube E., Kirtane A.J., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
20. Pfisterer M., HP B.-L.R., PT B., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C., and BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
21. Grines C.L., Bonow R.O., Sey Jr. D.E., Gardner T.J., Lockhart P.B., Moliterno D.J., O'Gara P., Whitlow P., and American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115 (2007) 813-818
22. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neil W.W., Schaff H.V., Whitlow P.L., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) 156-175
23. Chieffo A., Morici N., Maisano F., Bonizzoni E., Cosgrave J., Montorfano M., Airoldi F., Carlino M., Michev I., Melzi G., et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 113 (2006) 2542-2547
24. Lee M.S., Kapoor N., Jamal F., Czer L., Aragon J., Forrester J., Kar S., Dohad S., Kass R., Eigler N., Trento A., Shah P.K., and Makkar R.R. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 47 (2006) 864-870
25. Wood F.O., Saylors E.K., Schneider J.E., Jobe R.L., and Mann III J.T. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk. Catheter Cardiovasc Interv 71 (2008) 533-538
26. Dubois C., Dens J., Sinnaeve P., Belmans A., Van Cleemput J., Mendez M., Piessens J., and Desmet W. Results of percutaneous coronary intervention of the unprotected left main coronary artery in 143 patients and comparison of 30-day mortality to results of coronary artery bypass grafting. Am J Cardiol 101 (2008) 75-81
27. Sanmartín M., Baz J.A., Claro R., Asorey V., Durán D., Pradas G., and Iñiguez A. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol 100 (2007) 970-973